CHRNA7 and liver dysplastic nodule: These db/db mice are responsive to the α7 nicotinic acetylcholine receptor (α7nAChR) agonist GTS-21 which exerts a blood glucose-lowering effect8, and for this reason GTS-21 might be a previously unrecognized treatment for DN, as explored in the present study.